Mukai M, Ando K, Koike S, Ishikawa T, Ryu M, Nagashima T, Nagao K, Isono K
Gan To Kagaku Ryoho. 1986 Mar;13(3 Pt 1):556-62.
The combined effect of radiation with local administration of OK-432 was studied using natural fibrosarcoma (NFSa) of C3H mice that are less immunogenic and resistant to radiation (TCD 50, 83, 15 Gy). When 2KE of OK-432 was administered together with 1 X 10(6) tumor cells, tumor survival was inhibited in 7/8 (87.5%) of mice. Single local administration of OK-432 (2KE, 4KE, 8KE) showed hardly any effect on tumor survival. Combined treatment of 2KE of OK-432 and 4-Gy radiation, however, not only controlled tumor growth but also eradicated 1/5 (20%) of them, compared with single application of 45-Gy radiation. OK-432 worked most effectively when administered just before or after the application of X-rays. The optimum dose of OK-432 was studied by administering 2KE, 4KE and 8KE of the agent together with the application of 55-Gy radiation. 8KE groups showed the best eradication rate but 4KE groups showed the best cure rate. Therefore, the optimum dose was considered to be between 4KE and 8KE. With regard to histological effects, both the single radiation treatment and its combined treatment with OK-432 were most effective on the 6th day. The degree of degeneration and necrosis of tumor cells together with lymphocyte exudation were much higher in the combined treatment than in single radiation application.
利用C3H小鼠的天然纤维肉瘤(NFSa)研究了辐射与局部注射OK-432的联合效应,该肉瘤免疫原性较低且对辐射具有抗性(TCD50,83,15 Gy)。当将2KE的OK-432与1×10(6)个肿瘤细胞一起给药时,8只小鼠中有7只(87.5%)的肿瘤存活受到抑制。单独局部注射OK-432(2KE、4KE、8KE)对肿瘤存活几乎没有影响。然而,2KE的OK-432与4-Gy辐射联合治疗,不仅能控制肿瘤生长,而且与单独应用45-Gy辐射相比,还能根除其中1/5(20%)的肿瘤。OK-432在X射线照射前或照射后给药时效果最佳。通过将2KE、4KE和8KE的该制剂与55-Gy辐射联合应用来研究OK-432的最佳剂量。8KE组的根除率最高,但4KE组的治愈率最高。因此,最佳剂量被认为在4KE和8KE之间。关于组织学效应,单次辐射治疗及其与OK-432的联合治疗在第6天最为有效。联合治疗中肿瘤细胞的变性和坏死程度以及淋巴细胞渗出比单次辐射应用时高得多。